Hohimer Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $945K | Buy |
2,123
+26
| +1% | +$11.6K | 0.17% | 112 |
|
|
2025
Q1 | $1.02M | Sell |
2,097
-195
| -9% | -$94.5K | 0.2% | 106 |
|
|
2024
Q4 | $923K | Sell |
2,292
-28
| -1% | -$11.3K | 0.17% | 118 |
|
|
2024
Q3 | $1.08M | Buy |
2,320
+70
| +3% | +$32.6K | 0.23% | 111 |
|
|
2024
Q2 | $1.05M | Sell |
2,250
-633
| -22% | -$297K | 0.24% | 111 |
|
|
2024
Q1 | $1.21M | Sell |
2,883
-49
| -2% | -$20.5K | 0.28% | 96 |
|
|
2023
Q4 | $1.19M | Buy |
2,932
+24
| +0.8% | +$9.77K | 0.3% | 93 |
|
|
2023
Q3 | $1.01M | Buy |
2,908
+31
| +1% | +$10.8K | 0.29% | 95 |
|
|
2023
Q2 | $1.01M | Sell |
2,877
-76
| -3% | -$26.7K | 0.28% | 95 |
|
|
2023
Q1 | $930K | Sell |
2,953
-54
| -2% | -$17K | 0.27% | 94 |
|
|
2022
Q4 | $868K | Sell |
3,007
-19
| -0.6% | -$5.49K | 0.28% | 75 |
|
|
2022
Q3 | $876K | Sell |
3,026
-4
| -0.1% | -$1.16K | 0.28% | 93 |
|
|
2022
Q2 | $854K | Sell |
3,030
-3,275
| -52% | -$923K | 0.25% | 112 |
|
|
2022
Q1 | $1.65M | Buy |
6,305
+581
| +10% | +$152K | 0.32% | 93 |
|
|
2021
Q4 | $1.26M | Sell |
5,724
-211
| -4% | -$46.3K | 0.26% | 109 |
|
|
2021
Q3 | $1.08M | Buy |
5,935
+146
| +3% | +$26.5K | 0.23% | 116 |
|
|
2021
Q2 | $1.17M | Buy |
5,789
+2,859
| +98% | +$576K | 0.24% | 115 |
|
|
2021
Q1 | $630K | Sell |
2,930
-2,533
| -46% | -$545K | 0.15% | 131 |
|
|
2020
Q4 | $1.29M | Sell |
5,463
-33
| -0.6% | -$7.8K | 0.34% | 95 |
|
|
2020
Q3 | $1.21M | Buy |
5,496
+89
| +2% | +$19.6K | 0.35% | 97 |
|
|
2020
Q2 | $1.57M | Sell |
5,407
-401
| -7% | -$116K | 0.54% | 67 |
|
|
2020
Q1 | $1.56M | Sell |
5,808
-2,086
| -26% | -$560K | 0.66% | 62 |
|
|
2019
Q4 | $1.73M | Buy |
+7,894
| New | +$1.73M | 0.6% | 69 |
|